These drugs, known as GLP-1 receptor agonists, are part of a new class of weight loss medications that are shaking up treatment of obesity and diabetes
If you suspect you're experiencing side effects from Ozempic, report them to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) and discuss any concerns with your healthcare provider rather than discontinuing medication independently
GLP-1 users may differ from nonusers in ways that are not fully captured, such as socioeconomic status, health behaviors, disease severity, medication adherence, or access to care." Lakkis notes that the study also did not report how much weight participants lost, making it difficult to determine how much of the benefit may have been driven by weight reduction itself
Confusingly, Ozempic has become the byword for semaglutide products, regardless of whether a person is taking them for weight loss or diabetes
Theres no washout period needed between medications